Advertisement

Meta-analysis Comparing Multivessel Versus Culprit Coronary Arterial Revascularization for Patients With Non-ST-Segment Elevation Acute Coronary Syndromes

      We present a systematic review and meta-analysis comparing efficacy and safety outcomes between single procedure multivessel revascularization (MVR) and culprit vessel only revascularization in patients presenting with non-ST-segment-elevation acute coronary syndrome (NSTE-ACS). NSTE-ACS is the most common form of acute coronary syndrome (ACS), and multivessel disease is common. There is no consensus on the most efficacious single procedure revascularization strategy for patients undergoing percutaneous coronary intervention not meeting coronary artery bypass grafting criteria. Studies in PubMed and EMBASE databases were systematically reviewed, and 15 studies met criteria for inclusion in the meta-analysis. Baseline characteristics between the groups were similar. A random effects model was used to calculate odds ratios (OR) with 95% confidence intervals (CI). Heterogeneity of studies was assessed using Cochrane's Q and Higgins I2 tests. For short-term outcomes, patients who underwent MVR had higher rates of major adverse cardiac events (OR 1.14; 95% CI 1.01 to 1.29; p = 0.03); and stroke (OR 1.94; 95% CI 1.01 to 3.72; p = 0.05), but lower rates of urgent or emergent coronary artery bypass grafting (OR 0.35; 95% CI 0.29 to 0.43; p <0.00001). In the long-term, MVR patients had less frequent major adverse cardiac events (OR 0.76; 95% CI 0.61-0.93; p = 0.009), all-cause death (OR 0.83; 95% CI 0.71 to 0.97; p = 0.03), and repeat revascularization, (OR 0.62; 95% CI 0.42 to 0.90; p = 0.01). MVR following NSTE-ACS was associated with higher short-term risk, but long-term benefit. In conclusion, these results support the use of single procedure multivessel revascularization for NSTE-ACS patients who are suitable candidates at the time of percutaneous coronary intervention.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Go AS
        • Mozaffarian D
        • Roger VL
        • Benjamin EJ
        • Berry JD
        • Borden WB
        • Bravata DM
        • Dai S
        • Ford ES
        • Fox CS
        • Franco S
        • Fullerton HJ
        • Gillespie C
        • Hailpern SM
        • Heit JA
        • Howard VJ
        • Huffman MD
        • Kissela BM
        • Kittner SJ
        • Lackland DT
        • Lichtman JH
        • Lisabeth LD
        • Magid D
        • Marcus GM
        • Marelli A
        • Matchar DB
        • McGuire DK
        • Mohler ER
        • Moy CS
        • Mussolino ME
        • Nichol G
        • Paynter NP
        • Schreiner PJ
        • Sorlie PD
        • Stein J
        • Turan TN
        • Virani SS
        • Wong ND
        • Woo D
        • Turner MB
        • American Heart Association Statistics Committee and Stroke Statistics Subcommittee
        Heart disease and stroke statistics–2013 update: a report from the American Heart Association.
        Circulation. 2013; 127: e6-e245
        • Benjamin EJ
        • Muntner P
        • Alonso A
        • Bittencourt MS
        • Callaway Clifton W.
        • Carson AP
        • Chamberlain AM
        • Chang AR
        • Cheng S
        • Das SR
        • Delling FN
        • Djousse L
        • Elkind M.S.V.
        • Ferguson JF
        • Fornage M
        • Jordan LC
        • Khan SS.
        • Kissela BM
        • Knutson KL.
        • Kwan TW.
        • Lackland DT.
        • Lewis TT.
        • Lichtman JH
        • Longenecker CT.
        • Loop MS
        • Lutsey PL.
        • Martin SS.
        • Matsushita K
        • Moran AE.
        • Mussolino ME.
        • O'Flaherty M
        • Pandey A
        • Perak AM.
        • Rosamond WD.
        • Roth GA.
        • Sampson U.K.A.
        • Satou GM.
        • Schroeder EB.
        • Shah SH.
        • Spartano NL.
        • Stokes A
        • Tirschwell DL.
        • Tsao CW.
        • Turakhia MP.
        • VanWagner LB.
        • Wilkins JT.
        • Wong SS.
        • Virani SS
        Heart disease and stroke statistics—2019 update: a report from the American Heart Association.
        Circulation. 2019; 139: e56-e528
        • Amsterdam EA
        • Wenger NK
        • Brindis RG
        • Casey DE
        • Ganiats TG
        • Holmes DR
        • Jaffe AS
        • Jneid H
        • Kelly RF
        • Kontos MC
        • Levine GN
        • Liebson PR
        • Mukherjee D
        • Peterson ED
        • Sabatine MS
        • Smalling RW
        • Zieman SJ
        2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association task force on practice guidelines.
        J Am Coll Cardiol. 2014; 64: e139-e228
        • Roffi M
        • Patrono C
        • Collet J-P
        • Mueller C
        • Valgimigli M
        • Andreotti F
        • Bax JJ
        • Borger MA
        • Brotons C
        • Chew DP
        • Gencer B
        • Hasenfuss G
        • Kjeldsen K
        • Lancellotti P
        • Landmesser U
        • Mehilli J
        • Mukherjee D
        • Storey RF
        • Windecker S
        2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC).
        Eur Heart J. 2016; 37: 267-315
        • Brener SJ
        • Murphy SA
        • Gibson CM
        • DiBattiste PM
        • Demopoulos LA
        • Cannon CP
        Efficacy and safety of multivessel percutaneous revascularization and tirofiban therapy in patients with acute coronary syndromes.
        Am J Cardiol. 2002; 90: 631-633
        • Hassanin A
        • Brener SJ
        • Lansky AJ
        • Xu K
        • Stone GW
        Prognostic impact of multivessel versus culprit vessel only percutaneous intervention for patients with multivessel coronary artery disease presenting with acute coronary syndrome.
        EuroIntervention. 2015; 11: 293-300
        • Brener SJ
        • Milford-Beland S
        • Roe MT
        • Bhatt DL
        • Weintraub WS
        • Brindis RG
        Culprit-only or multivessel revascularization in patients with acute coronary syndromes.
        Am Heart J. 2008; 155: 140-146
        • Bauer T
        • Zeymer U
        • Hochadel M
        • Möllmann H
        • Weidinger F
        • Zahn R
        • Nef HM
        • Hamm CW
        • Marco J
        • Gitt AK
        Prima-vista multi-vessel percutaneous coronary intervention in haemodynamically stable patients with acute coronary syndromes: analysis of over 4.400 patients in the EHS-PCI registry.
        Int J Cardiol. 2013; 166: 596-600
        • Shishehbor MH
        • Lauer MS
        • Singh IM
        • Chew DP
        • Karha J
        • Brener SJ
        • Moliterno DJ
        • Ellis SG
        • Topol EJ
        • Bhatt DL
        In unstable angina or non–ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting?.
        J Am Coll Cardiol. 2007; 49: 849-854
        • Mariani G
        • De Servi S
        • Dellavalle A
        • Repetto S
        • Chierchia S
        • D'Urbano M
        • Repetto A
        • Klersy C
        • ROSAI Study Group
        Complete or incomplete percutaneous coronary revascularization in patients with unstable angina in stent era: Are early and one-year results different?.
        Catheter Cardiovasc Interv. 2001; 54: 448-453
        • Zapata GO
        • Lasave LI
        • Kozak F
        • Damonte A
        • Meiriño A
        • Rossi M
        • Carbó S
        • Pollice A
        • Paolasso E
        • Picabea E
        Culprit-only or multivessel percutaneous coronary stenting in patients with non-ST-segment elevation acute coronary syndromes: one-year follow-up.
        J Interv Cardiol. 2009; 22: 329-335
        • Kim MC
        • Jeong MH
        • Ahn Y
        • Kim JH
        • Chae SC
        • Kim YJ
        • Hur SH
        • Seong IW
        • Hong TJ
        • Choi DH
        • Cho MC
        • Kim CJ
        • Seung KB
        • Chung WS
        • Jang YS
        • Cho SY
        • Rha SW
        • Bae JH
        • Cho JG
        • Park SJ
        What is optimal revascularization strategy in patients with multivessel coronary artery disease in non-ST-elevation myocardial infarction? Multivessel or culprit-only revascularization.
        Int J Cardiol. 2011; 153: 148-153
        • Lee HJ
        • Song YB
        • Hahn J-Y
        • Kim SM
        • Yang JH
        • Choi JH
        • Choi S-H
        • Choi J-H
        • Lee SH
        • Gwon H-C
        Multivessel vs single-vessel revascularization in patients with non–ST-segment elevation acute coronary syndrome and multivessel disease in the drug-eluting stent Era.
        Clin Cardiol. 2011; 34: 160-165
        • Onuma Y
        • Muramatsu T
        • Girasis C
        • Kukreja N
        • Garcia-Garcia H
        • Daemen J
        • Gonzalo N
        • Piazza N
        • Einthoven J
        • Domburg R van
        • Serruys PW
        Single-vessel or multivessel PCI in patients with multivessel disease presenting with non-ST-elevation acute coronary syndromes.
        EuroIntervention. 2013; 9: 916-922
        • Palmer ND
        • Causer JP
        • Ramsdale DR
        • Perry RA
        Effect of completeness of revascularization on clinical outcome in patients with multivessel disease presenting with unstable angina who undergo percutaneous coronary intervention.
        J Invasive Cardiol. 2004; 16: 185-188
        • Correia C
        • Galvão Braga C
        • Martins J
        • Arantes C
        • Abreu G
        • Quina C
        • Salgado A
        • Álvares Pereira M
        • Costa J
        • Marques J
        Multivessel vs. culprit-only revascularization in patients with non-ST-elevation acute coronary syndromes and multivessel coronary disease.
        Revista Portuguesa de Cardiologia. 2018; 37: 143-154
        • Quadri G
        • D'Ascenzo F
        • Moretti C
        • D'Amico M
        • Raposeiras-Roubin S
        • Abu-Assi E
        • Henriques JPS
        • Saucedo J
        • Gonzalez-Juanatey JR
        • Wilton SB
        • Kikkert WJ
        • Nunez-Gil I
        • Ariza-Sole A
        • Song X
        • Alexopolous D
        • Liebetrau C
        • Kawaji T
        • Huczek Z
        • Nie S-P
        • Fujii T
        • Correia L
        • Kawashiri M
        • Garcia-Acuna JM
        • Southern D
        • Alfonso E
        • Terol B
        • Garay A
        • Zhang D
        • Chen Y
        • Xanthopoulou I
        • Osman O
        • Helge M
        • Hiroki S
        • Pierluigi O
        • Antonio M
        • Francesca G
        • Silvia S
        • Michal K
        • Krzysztof F
        • Xiao W
        • Yan Y
        • Jing-Yao F
        • Yuji I
        • Takuya N
        • Kenji S
        • Masakazu Y
        • Oliver K
        • Sasko K
        • Ferdinando V
        • Fiorenzo G
        Complete or incomplete coronary revascularisation in patients with myocardial infarction and multivessel disease: a propensity score analysis from the “real-life” BleeMACS (Bleeding complications in a Multicenter registry of patients discharged with diagnosis of Acute Coronary Syndrome) registry.
        EuroIntervention. 2017; 13: 407-414
        • Rathod KS
        • Koganti S
        • Jain AK
        • Astroulakis Z
        • Lim P
        • Rakhit R
        • Kalra SS
        • Dalby MC
        • O'Mahony C
        • Malik IS
        • Knight CJ
        • Mathur A
        • Redwood S
        • Sirker A
        • MacCarthy PA
        • Smith EJ
        • Wragg A
        • Jones DA
        Complete versus culprit-only lesion intervention in patients with acute coronary syndromes.
        J Am Coll Cardiol. 2018; 72: 1989-1999
        • Wang TY
        • McCoy LA
        • Bhatt DL
        • Rao SV
        • Roe MT
        • Resnic FS
        • Cavender MA
        • Messenger JC
        • Peterson ED
        Multivessel vs culprit-only percutaneous coronary intervention among patients 65 years or older with acute myocardial infarction.
        Am Heart J. 2016; 172: 9-18
        • Jang J-S
        • Jin H-Y
        • Seo J-S
        • Yang T-H
        • Kim D-K
        • Kim D-S
        • Cho K-I
        • Kim B-H
        • Park YH
        • Je H-G
        Meta-analysis of multivessel versus culprit-only percutaneous coronary intervention in patients with non–ST-segment elevation acute coronary syndrome and multivessel coronary disease.
        Am J Cardiol. 2015; 115: 1027-1032
        • Qiao Y
        • Li W
        • Mohamed S
        • Nie S
        • Du X
        • Zhang Y
        • Jia C
        • Wang X
        • Liu X
        • Ma C
        A comparison of multivessel and culprit vessel percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients with multivessel disease: a meta-analysis.
        EuroIntervention. 2015; 11: 525-532
        • Mehran R.
        Contrast-induced nephropathy remains a serious complication of PCI.
        J Interv Cardiol. 2007; 20: 236-240
        • De Innocentiis C
        • Zimarino M
        • De Caterina R
        Is complete revascularisation mandated for all patients with multivessel coronary artery disease?.
        Interv Cardiol. 2018; 13: 45-50
        • Gaffar R
        • Habib B
        • Filion KB
        • Reynier P
        • Eisenberg MJ
        Optimal timing of complete revascularization in acute coronary syndrome: a systematic review and meta‐analysis.
        J Am Heart Assoc. 2017; 6
        • El-Hayek GE
        • Gershlick AH
        • Hong MK
        • Casso Dominguez A
        • Banning A
        • Afshar AE
        • Herzog E
        • Tamis-Holland JE
        Meta-analysis of randomized controlled trials comparing multivessel versus culprit-only revascularization for patients with ST-segment elevation myocardial infarction and multivessel disease undergoing primary percutaneous coronary intervention.
        Am J Cardiol. 2015; 115: 1481-1486
        • Bangalore S
        • Toklu B
        • Stone GW
        Meta-analysis of culprit-only versus multivessel percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction and multivessel coronary disease.
        Am J Cardiol. 2018; 121: 529-536
        • Généreux P
        • Palmerini T
        • Caixeta A
        • Rosner G
        • Green P
        • Dressler O
        • Xu K
        • Parise H
        • Mehran R
        • Serruys PW
        • Stone GW
        Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) Score.
        J Am Coll Cardiol. 2012; 59: 2165-2174
        • Heitner John F.
        • Senthilkumar Annamalai
        • Kevin Harrison J.
        • Klem Igor
        • Sketch Michael H.
        • Ivanov Alexandr
        • Hamo Carine
        • Van Assche Lowie
        • White James
        • Washam Jeffrey
        • Patel Manesh R.
        • Bekkers Sebastiaan C.A.M.
        • Smulders Martijn W.
        • Sacchi Terrence J.
        • Kim Raymond J.
        Identifying the infarct-related artery in patients with non–ST-segment–elevation myocardial infarction.
        Circ Cardiovasc Interv. 2019; 12e007305
        • Windecker S
        • Alfonso F
        • Collet J-P
        • Cremer J
        • Falk V
        • Filippatos G
        • Hamm C
        • Head SJ
        • Jüni P
        • Kappetein AP
        • Kastrati A
        • Knuuti J
        • Landmesser U
        • Laufer G
        • Neumann F-J
        • Richter DJ
        • Schauerte P
        • Sousa Uva M
        • Stefanini GG
        • Taggart DP
        • Torracca L
        • Valgimigli M
        • Wijns W
        • Witkowski A
        2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
        Eur Heart J. 2014; 35: 2541-2619